Biocytogen started to build the large animal translational research platform in 2020 to perform canine tumor clinical screening and canine clinical trials. The platform aims to serve translational research and accelerate the development of novel anti-tumor drugs.

• Clinical screening technology platform for large animal tumors

• Technology platform for large animal clinical trials